ClinConnect ClinConnect Logo
Search / Trial NCT06129942

Light Therapy in Parkinson's Disease

Launched by SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY · Nov 10, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of bright light therapy on people with Parkinson's disease, particularly focusing on how it may help with movement problems and sleep issues. Participants in the trial will be patients diagnosed with Parkinson's disease who are in stages 2 or 3 of the condition, meaning their symptoms are moderate but not too severe. To join the study, individuals must have been on stable medication for at least a month and agree not to change their medication during the trial.

Eligible participants should be between 18 and 65 years old and should not have serious visual or cognitive impairments. They also should not be taking certain medications, like sleeping pills or antidepressants, unless they have been stable for over three months. If someone decides to participate, they can expect to undergo light therapy sessions while being closely monitored for any changes in their motor symptoms and sleep patterns. This trial is currently recruiting participants, so it’s a great opportunity for those looking for new ways to manage their Parkinson’s symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • According to the criteria of PD diagnosis of the MDS, PD patients were selected as the research object. The clinical symptoms of PD patients were consistent with Hoehn and Yahr stages 2-3.
  • All PD patients have maintained stable drug treatment for at least one month, signed clinical informed consent and agreed not to adjust drugs throughout the light test and follow-up period.
  • Exclusion Criteria:
  • Using hypnotic or stimulating drugs.
  • Using antidepressants, except stable drugs maintained for more than three months;
  • Visual impairment, such as cataract, glaucoma, blindness, etc;
  • Cognitive impairment (MMSE \< 24);
  • There are uncontrollable hallucinations and mental diseases;
  • There are sleep phase delay / advance syndrome, shift work, jet lag, etc

About Second Affiliated Hospital Of Soochow University

The Second Affiliated Hospital of Soochow University is a leading medical institution in China, renowned for its commitment to advanced healthcare and clinical research. As a prominent sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields to facilitate innovative treatments and improve patient outcomes. With a multidisciplinary team of experienced clinicians and researchers, the institution aims to contribute to the global medical community by advancing evidence-based practices and fostering collaborations that enhance therapeutic options. Through rigorous trial management and adherence to ethical standards, the Second Affiliated Hospital is dedicated to enhancing the quality of care and driving medical advancements.

Locations

Suzhou, Jiangsu, China

Patients applied

0 patients applied

Trial Officials

Chun-Feng Liu, PhD

Principal Investigator

Second Affiliated Hospital of Soochow University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported